These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24951724)

  • 1. The anorexic effect of Ex4/Fc through GLP-1 receptor activation in high-fat diet fed mice.
    Liu R; Ma D; Li Y; Hu R; Peng Y; Wang Q
    Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):675-81. PubMed ID: 24951724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes.
    Soltani N; Kumar M; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jun; 14(12):981-8. PubMed ID: 17410180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
    Burmeister MA; Ayala J; Drucker DJ; Ayala JE
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
    Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
    Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
    Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
    Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
    Mul JD; Begg DP; Barrera JG; Li B; Matter EK; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
    Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R68-77. PubMed ID: 23616105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
    Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
    Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
    Williams DL; Hyvarinen N; Lilly N; Kay K; Dossat A; Parise E; Torregrossa AM
    Physiol Behav; 2011 Jul; 103(5):557-64. PubMed ID: 21515295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity against a therapeutic xenoprotein/Fc construct delivered by gene transfer is reduced through binding to the inhibitory receptor FcγRIIb.
    Liang Y; Qiu H; Glinka Y; Lazarus AH; Ni H; Prud'homme GJ; Wang Q
    J Gene Med; 2011 Sep; 13(9):470-7. PubMed ID: 21786368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL; Huang Q; Cao X; Drucker DJ
    Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.
    Talsania T; Anini Y; Siu S; Drucker DJ; Brubaker PL
    Endocrinology; 2005 Sep; 146(9):3748-56. PubMed ID: 15932924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
    Terrill SJ; Jackson CM; Greene HE; Lilly N; Maske CB; Vallejo S; Williams DL
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R124-32. PubMed ID: 27194565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation.
    Williams DL; Baskin DG; Schwartz MW
    Diabetes; 2006 Dec; 55(12):3387-93. PubMed ID: 17130484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 shows no effects on the prostatic index in high-fat-diet-fed rat with benign prostatic hyperplasia by improving insulin resistance.
    Zheng JX; Xiao YC; Hu YR; Hao M; Kuang HY
    Andrologia; 2015 Mar; 47(2):236-42. PubMed ID: 24605934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats.
    Malendowicz LK; Macchi C; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
    Int J Mol Med; 2003 Jun; 11(6):763-6. PubMed ID: 12736719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucagon-like peptide-1 receptor in the ventromedial hypothalamus reduces short-term food intake in male mice by regulating nutrient sensor activity.
    Burmeister MA; Brown JD; Ayala JE; Stoffers DA; Sandoval DA; Seeley RJ; Ayala JE
    Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E651-E662. PubMed ID: 28811293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth.
    Nomiyama T; Kawanami T; Irie S; Hamaguchi Y; Terawaki Y; Murase K; Tsutsumi Y; Nagaishi R; Tanabe M; Morinaga H; Tanaka T; Mizoguchi M; Nabeshima K; Tanaka M; Yanase T
    Diabetes; 2014 Nov; 63(11):3891-905. PubMed ID: 24879833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time trafficking and signaling of the glucagon-like peptide-1 receptor.
    Roed SN; Wismann P; Underwood CR; Kulahin N; Iversen H; Cappelen KA; Schäffer L; Lehtonen J; Hecksher-Soerensen J; Secher A; Mathiesen JM; Bräuner-Osborne H; Whistler JL; Knudsen SM; Waldhoer M
    Mol Cell Endocrinol; 2014 Feb; 382(2):938-49. PubMed ID: 24275181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.